Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Cost of RevenueDepreciation & Amortization (IS)EBIATLong-Term Debt IssuancesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Avai Bio (AVAI) Gross Profit (2019 - 2023)

Avai Bio's Gross Profit history spans 4 years, with the latest figure at $1.0 for Q1 2023.

  • On a quarterly basis, Gross Profit changed N/A to $1.0 in Q1 2023 year-over-year; TTM through Mar 2023 was -$40453.0, a N/A change, with the full-year FY2023 number at -$40453.0, up 80.81% from a year prior.
  • Gross Profit hit $1.0 in Q1 2023 for Avai Bio, up from -$71537.0 in the prior quarter.
  • Over the last five years, Gross Profit for AVAI hit a ceiling of $346194.0 in Q4 2020 and a floor of -$262334.0 in Q1 2020.
  • Historically, Gross Profit has averaged $24603.3 across 4 years, with a median of $6592.0 in 2022.
  • The widest YoY moves for Gross Profit: up 1310.52% in 2020, down 1310.52% in 2020.
  • Tracing AVAI's Gross Profit over 4 years: stood at $6000.0 in 2019, then skyrocketed by 5669.9% to $346194.0 in 2020, then plummeted by 120.66% to -$71537.0 in 2022, then surged by 100.0% to $1.0 in 2023.
  • Business Quant data shows Gross Profit for AVAI at $1.0 in Q1 2023, -$71537.0 in Q4 2022, and $6592.0 in Q3 2022.